Meg Jardine's Publications

• Risk factors for incident kidney disease in older adults: an Australian prospective population-based study

  Journal articles

  2022

  Internal Medicine Journal

• A Novel Risk Prediction Model for Severe Acute Kidney Injury in Intensive Care Unit Patients Receiving Fluid Resuscitation

  Journal articles

  2022

  Frontiers in Cardiovascular Medicine

• Premature Death in Kidney Transplant Recipients: The Time for Trials is Now

  Journal articles

  2022

  Journal of the American Society of Nephrology

• Comparative effectiveness of SGLT2i versus GLP1-RA on cardiovascular outcomes in routine clinical practice

  Journal articles

  2022

  International Journal of Cardiology

• SGLT2 inhibitors may prevent diabetes

  Journal articles

  2022

  Nature Reviews Nephrology

• Digital health and artificial intelligence in kidney research: A report from the 2020 Kidney Disease Clinical Trialists (KDCT) meeting

  Journal articles

  2022

  Nephrology Dialysis Transplantation

• Prior Cardiovascular TreatmentsA Key Characteristic in Determining Medication Adherence After an Acute Myocardial Infarction

  Journal articles

  2022

  Frontiers in Pharmacology

• Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE Trial

  Journal articles

  2022

  Clinical Journal of the American Society of Nephrology

• Antiplatelet agents for chronic kidney disease

  Journal articles

  2022

  Cochrane Database of Systematic Reviews

• GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes

  Journal articles

  2022

  Kidney International

• Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial

  Journal articles

  2022

  American Journal of Kidney Diseases

• Findings of Sodium-Glucose Cotransporter-2 Inhibitor Kidney Outcome Trials Applied to a Canadian Chronic Kidney Disease Population: A Retrospective Cohort Study

  Journal articles

  2022

  Canadian Journal of Kidney Health and Disease

• Dialysis Dose and Adequacy for Hemodialysis

  Book Chapters

  2022

  Evidence-Based Nephrology, Second Edition: Volumes 1,2

• Alternative Clinical Trial Designs for Nephrology Research

  Book Chapters

  2022

  Innovations in Nephrology: Breakthrough Technologies in Kidney Disease Care

• Angiotensin receptor blockers for the treatment of covid-19: Pragmatic, adaptive, multicentre, phase 3, randomised controlled trial

  Journal articles

  2022

  BMJ

• Risk Factors for Fracture in Patients with Coexisting Chronic Kidney Disease and Type 2 Diabetes: An Observational Analysis from the CREDENCE Trial

  Journal articles

  2022

  Journal of Diabetes Research

• Can Peer Review Be Kinder? Supportive Peer Review: A Re-Commitment to Kindness and a Call to Action

  Journal articles

  2022

  Canadian Journal of Kidney Health and Disease

• Renal, cardiovascular and safety outcomes of canagliflozin in patients with type2 diabetes and nephropathy in East and South-East Asian countries: Results from the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation Trial

  Journal articles

  2022

  Journal of Diabetes Investigation

• Sex and Gender Considerations in Randomized Controlled Trials in Adults Receiving Chronic Dialysis: A Meta-Epidemiologic Study

  Journal articles

  2022

  Journal of the American Society of Nephrology

• INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-7 PREDICTS CARDIOVASCULAR AND RENAL OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE: THE CREDENCE TRIAL

  Journal articles

  2022

  Journal of the American College of Cardiology

• POS-527 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Atrasentan in Patients with IgA Nephropathy (The ALIGN Study)

  Conference Posters

  2022

• POS-019 A NOVEL RISK PREDICTION MODEL FOR SERVE ACUTE KIDNEY INJURY IN INTENSIVE CARE UNIT PATIENTS RECEIVING FLUID RESUSCITATION

  Conference Abstracts

  2022

  Kidney International Reports

• Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: The CREDENCE trial

  Journal articles

  2021

  European Heart Journal

• The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics

  Journal articles

  2021

  American Journal of Nephrology

• Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial

  Journal articles

  2021

  Trials

• Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysis

  Journal articles

  2021

  Diabetes, Obesity and Metabolism